Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Plans Guidance This Year On Co-Development Of Diagnostics And Drugs

This article was originally published in The Gray Sheet

Executive Summary

FDA expects to complete a guidance document on co-development of diagnostics and drugs used for personalized medicine by the end of this year, FDA Commissioner Margaret Hamburg said at a meeting in Washington, D.C., Feb. 25
Advertisement

Related Content

New J&J Drug Candidates Don't Go It Alone: Companion Dx Are Standard
New J&J Drug Candidates Don't Go It Alone: Companion Dx Are Standard
New J&J Drug Candidates Don't Go It Alone: Companion Dx Are Standard
FDA Aims For Flexibility In Upcoming Drug/Test Co-Development Guidance
FDA Aims For Flexibility In Upcoming Drug/Test Co-Development Guidance
FDA Prepares To Issue Draft Biomarker Qualifications Guidance
FDA Prepares To Issue Draft Biomarker Qualifications Guidance
Dx Groups To FDA: Time For Companion Diagnostics Guidance Is Now
FDA Diagnostics Office Seeks Bigger Role In Personalized Medicine
FDA Diagnostics Office Seeks Bigger Role In Personalized Medicine

Topics

Advertisement
UsernamePublicRestriction

Register

MT028551

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel